<DOC>
	<DOCNO>NCT01480518</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor understand well patient respond treatment . PURPOSE : This research study study biomarkers tissue sample patient Ewing sarcoma .</brief_summary>
	<brief_title>Biomarkers Tissue Samples From Patients With Ewing Sarcoma</brief_title>
	<detailed_description>OBJECTIVES : - To describe spectrum GGAA-microsatellite polymorphism specific loci genomic DNA prepare Ewing sarcoma tumor specimen . - To determine difference GGAA-microsatellite polymorphism genomic DNA prepare Ewing sarcoma tumor specimen compare non-afflicted European African normal genomic DNA . - To determine GGAA-microsatellite polymorphism specific loci genomic DNA prepare Ewing 's sarcoma tumor specimens correlate disease outcome patient treat COG protocol AEWS0031 . - To determine whether whole-genome amplification introduces alteration GGAA-microsatellites compare non-amplified genomic DNA . OUTLINE : Genomic PCR use amplify microsatellites NR0B1 GSTM4 promoter . In addition determine microsatellite size , microsatellite sequence follow clone pCR4 vector ( Invitrogen ) use standard topoisomerase cloning protocol .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Specimens patient Ewing sarcoma use protocol COGAEWS08B1 Obtained patient sample take patient enrol COGAEWS0031 Whole genomeamplified DNA use PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>localize Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
</DOC>